Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.

Lee MSJ, Natsume-Kitatani Y, Temizoz B, Fujita Y, Konishi A, Matsuda K, Igari Y, Tsukui T, Kobiyama K, Kuroda E, Onishi M, Marichal T, Ise W, Inoue T, Kurosaki T, Mizuguchi K, Akira S, Ishii KJ, Coban C.

Eur J Immunol. 2019 May 14. doi: 10.1002/eji.201848084. [Epub ahead of print]

PMID:
31087643
2.

Rapid Quantification of NETs In Vitro and in Whole Blood Samples by Imaging Flow Cytometry.

Lelliott PM, Momota M, Lee MSJ, Kuroda E, Iijima N, Ishii KJ, Coban C.

Cytometry A. 2019 May;95(5):565-578. doi: 10.1002/cyto.a.23767. Epub 2019 Apr 15.

PMID:
30985081
3.

DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.

Hayashi T, Momota M, Kuroda E, Kusakabe T, Kobari S, Makisaka K, Ohno Y, Suzuki Y, Nakagawa F, Lee MSJ, Coban C, Onodera R, Higashi T, Motoyama K, Ishii KJ, Arima H.

Front Immunol. 2018 Nov 20;9:2619. doi: 10.3389/fimmu.2018.02619. eCollection 2018.

4.

Does it take three to tango? An unsuspected multimorbidity of CD8+ T cell lymphoproliferative disorder, malaria, and EBV infection.

Ekemen S, Uzay A, Bassullu N, Dikicioglu-Cetin E, Matsuda K, Ince U, Coban C.

Malar J. 2018 Oct 5;17(1):349. doi: 10.1186/s12936-018-2497-9.

5.

Tissue-specific immunopathology during malaria infection.

Coban C, Lee MSJ, Ishii KJ.

Nat Rev Immunol. 2018 Apr;18(4):266-278. doi: 10.1038/nri.2017.138. Epub 2018 Jan 15. Review.

PMID:
29332936
6.

Unforeseen pathologies caused by malaria.

Lee MSJ, Coban C.

Int Immunol. 2018 Mar 10;30(3):121-129. doi: 10.1093/intimm/dxx076. Review.

PMID:
29300968
7.

Erythrocyte β spectrin can be genetically targeted to protect mice from malaria.

Lelliott PM, Huang HM, Dixon MW, Namvar A, Blanch AJ, Rajagopal V, Tilley L, Coban C, McMorran BJ, Foote SJ, Burgio G.

Blood Adv. 2017 Dec 12;1(26):2624-2636. doi: 10.1182/bloodadvances.2017009274. eCollection 2017 Dec 12.

8.

Plasmodium products persist in the bone marrow and promote chronic bone loss.

Lee MSJ, Maruyama K, Fujita Y, Konishi A, Lelliott PM, Itagaki S, Horii T, Lin JW, Khan SM, Kuroda E, Akira S, Ishii KJ, Coban C.

Sci Immunol. 2017 Jun 2;2(12). pii: eaam8093. doi: 10.1126/sciimmunol.aam8093.

PMID:
28783657
9.

A distinct subpopulation of CD25- T-follicular regulatory cells localizes in the germinal centers.

Wing JB, Kitagawa Y, Locci M, Hume H, Tay C, Morita T, Kidani Y, Matsuda K, Inoue T, Kurosaki T, Crotty S, Coban C, Ohkura N, Sakaguchi S.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6400-E6409. doi: 10.1073/pnas.1705551114. Epub 2017 Jul 11.

10.

Bacterial secretion system skews the fate of Legionella-containing vacuoles towards LC3-associated phagocytosis.

Hubber A, Kubori T, Coban C, Matsuzawa T, Ogawa M, Kawabata T, Yoshimori T, Nagai H.

Sci Rep. 2017 Mar 20;7:44795. doi: 10.1038/srep44795.

11.

Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1α Release to Promote Inducible Bronchus-Associated Lymphoid Tissue Formation.

Kuroda E, Ozasa K, Temizoz B, Ohata K, Koo CX, Kanuma T, Kusakabe T, Kobari S, Horie M, Morimoto Y, Nakajima S, Kabashima K, Ziegler SF, Iwakura Y, Ise W, Kurosaki T, Nagatake T, Kunisawa J, Takemura N, Uematsu S, Hayashi M, Aoshi T, Kobiyama K, Coban C, Ishii KJ.

Immunity. 2016 Dec 20;45(6):1299-1310. doi: 10.1016/j.immuni.2016.11.010.

12.

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines.

Hayashi M, Aoshi T, Haseda Y, Kobiyama K, Wijaya E, Nakatsu N, Igarashi Y, Standley DM, Yamada H, Honda-Okubo Y, Hara H, Saito T, Takai T, Coban C, Petrovsky N, Ishii KJ.

EBioMedicine. 2017 Feb;15:127-136. doi: 10.1016/j.ebiom.2016.11.015. Epub 2016 Dec 1.

13.

Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.

Kitahata Y, Kanuma T, Hayashi M, Kobayashi N, Ozasa K, Kusakabe T, Temizoz B, Kuroda E, Yamaue H, Coban C, Yamamoto T, Kobiyama K, Aoshi T, Ishii KJ.

Oncotarget. 2016 Aug 2;7(31):48860-48869. doi: 10.18632/oncotarget.10379.

14.

RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine.

Hayashi M, Aoshi T, Ozasa K, Kusakabe T, Momota M, Haseda Y, Kobari S, Kuroda E, Kobiyama K, Coban C, Ishii KJ.

Sci Rep. 2016 Jul 4;6:29165. doi: 10.1038/srep29165.

15.

IFN-γ protects hepatocytes against Plasmodium vivax infection via LAP-like degradation of sporozoites.

Lelliott PM, Coban C.

Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):6813-5. doi: 10.1073/pnas.1607007113. Epub 2016 Jun 10. No abstract available.

16.

Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation.

Lee MS, Igari Y, Tsukui T, Ishii KJ, Coban C.

Vaccine. 2016 Apr 19;34(18):2055-61. doi: 10.1016/j.vaccine.2016.02.064. Epub 2016 Mar 11. Review.

PMID:
26976665
17.

Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use.

Aoshi T, Haseda Y, Kobiyama K, Narita H, Sato H, Nankai H, Mochizuki S, Sakurai K, Katakai Y, Yasutomi Y, Kuroda E, Coban C, Ishii KJ.

J Immunol Res. 2015;2015:316364. doi: 10.1155/2015/316364. Epub 2015 Aug 25.

18.

Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen.

Onishi M, Ozasa K, Kobiyama K, Ohata K, Kitano M, Taniguchi K, Homma T, Kobayashi M, Sato A, Katakai Y, Yasutomi Y, Wijaya E, Igarashi Y, Nakatsu N, Ise W, Inoue T, Yamada H, Vandenbon A, Standley DM, Kurosaki T, Coban C, Aoshi T, Kuroda E, Ishii KJ.

J Immunol. 2015 Mar 15;194(6):2673-82. doi: 10.4049/jimmunol.1402027. Epub 2015 Feb 13.

19.

Label-free Raman imaging of the macrophage response to the malaria pigment hemozoin.

Hobro AJ, Pavillon N, Fujita K, Ozkan M, Coban C, Smith NI.

Analyst. 2015 Apr 7;140(7):2350-9. doi: 10.1039/c4an01850h.

PMID:
25646175
20.

Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine.

Uraki R, Das SC, Hatta M, Kiso M, Iwatsuki-Horimoto K, Ozawa M, Coban C, Ishii KJ, Kawaoka Y.

Vaccine. 2014 Sep 15;32(41):5295-300. doi: 10.1016/j.vaccine.2014.07.079. Epub 2014 Aug 6.

21.

Olfactory plays a key role in spatiotemporal pathogenesis of cerebral malaria.

Zhao H, Aoshi T, Kawai S, Mori Y, Konishi A, Ozkan M, Fujita Y, Haseda Y, Shimizu M, Kohyama M, Kobiyama K, Eto K, Nabekura J, Horii T, Ishino T, Yuda M, Hemmi H, Kaisho T, Akira S, Kinoshita M, Tohyama K, Yoshioka Y, Ishii KJ, Coban C.

Cell Host Microbe. 2014 May 14;15(5):551-63. doi: 10.1016/j.chom.2014.04.008.

22.

Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets.

Onishi M, Kitano M, Taniguchi K, Homma T, Kobayashi M, Sato A, Coban C, Ishii KJ.

Vaccine. 2014 May 23;32(25):3004-9. doi: 10.1016/j.vaccine.2014.03.072. Epub 2014 Apr 8.

23.

Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist.

Kobiyama K, Aoshi T, Narita H, Kuroda E, Hayashi M, Tetsutani K, Koyama S, Mochizuki S, Sakurai K, Katakai Y, Yasutomi Y, Saijo S, Iwakura Y, Akira S, Coban C, Ishii KJ.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3086-91. doi: 10.1073/pnas.1319268111. Epub 2014 Feb 10.

24.

DNA vaccines: a simple DNA sensing matter?

Coban C, Kobiyama K, Jounai N, Tozuka M, Ishii KJ.

Hum Vaccin Immunother. 2013 Oct;9(10):2216-21. doi: 10.4161/hv.25893. Epub 2013 Aug 2. Review.

25.

Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects.

Kuroda E, Coban C, Ishii KJ.

Int Rev Immunol. 2013 Apr;32(2):209-20. doi: 10.3109/08830185.2013.773326. Review.

26.

The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant.

Tang CK, Aoshi T, Jounai N, Ito J, Ohata K, Kobiyama K, Dessailly BH, Kuroda E, Akira S, Mizuguchi K, Coban C, Ishii KJ.

PLoS One. 2013;8(3):e60038. doi: 10.1371/journal.pone.0060038. Epub 2013 Mar 21.

27.

Raman spectroscopic analysis of malaria disease progression via blood and plasma samples.

Hobro AJ, Konishi A, Coban C, Smith NI.

Analyst. 2013 Jul 21;138(14):3927-33. doi: 10.1039/c3an00255a.

PMID:
23529513
28.

Detection and size measurement of individual hemozoin nanocrystals in aquatic environment using a whispering gallery mode resonator.

Kim W, Ozdemir SK, Zhu J, Faraz M, Coban C, Yang L.

Opt Express. 2012 Dec 31;20(28):29426-46. doi: 10.1364/OE.20.029426.

PMID:
23388770
29.

TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models.

Tougan T, Aoshi T, Coban C, Katakai Y, Kai C, Yasutomi Y, Ishii KJ, Horii T.

Hum Vaccin Immunother. 2013 Feb;9(2):283-90. Epub 2013 Jan 4.

30.

Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination.

Kobiyama K, Jounai N, Aoshi T, Tozuka M, Takeshita F, Coban C, Ishii KJ.

Vaccines (Basel). 2013 Jul 18;1(3):278-92. doi: 10.3390/vaccines1030278. Review.

31.

Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism.

Zhao H, Konishi A, Fujita Y, Yagi M, Ohata K, Aoshi T, Itagaki S, Sato S, Narita H, Abdelgelil NH, Inoue M, Culleton R, Kaneko O, Nakagawa A, Horii T, Akira S, Ishii KJ, Coban C.

Cell Host Microbe. 2012 Nov 15;12(5):705-16. doi: 10.1016/j.chom.2012.10.010.

32.

The origins of African Plasmodium vivax; insights from mitochondrial genome sequencing.

Culleton R, Coban C, Zeyrek FY, Cravo P, Kaneko A, Randrianarivelojosia M, Andrianaranjaka V, Kano S, Farnert A, Arez AP, Sharp PM, Carter R, Tanabe K.

PLoS One. 2011;6(12):e29137. doi: 10.1371/journal.pone.0029137. Epub 2011 Dec 14.

33.

Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax.

Yildiz Zeyrek F, Palacpac N, Yuksel F, Yagi M, Honjo K, Fujita Y, Arisue N, Takeo S, Tanabe K, Horii T, Tsuboi T, Ishii KJ, Coban C.

PLoS One. 2011;6(11):e28126. doi: 10.1371/journal.pone.0028126. Epub 2011 Nov 29.

34.

Novel strategies to improve DNA vaccine immunogenicity.

Coban C, Kobiyama K, Aoshi T, Takeshita F, Horii T, Akira S, Ishii KJ.

Curr Gene Ther. 2011 Dec;11(6):479-84. Review.

PMID:
22023477
35.

DNA released from dying host cells mediates aluminum adjuvant activity.

Marichal T, Ohata K, Bedoret D, Mesnil C, Sabatel C, Kobiyama K, Lekeux P, Coban C, Akira S, Ishii KJ, Bureau F, Desmet CJ.

Nat Med. 2011 Jul 17;17(8):996-1002. doi: 10.1038/nm.2403.

PMID:
21765404
36.

Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms.

Kuroda E, Ishii KJ, Uematsu S, Ohata K, Coban C, Akira S, Aritake K, Urade Y, Morimoto Y.

Immunity. 2011 Apr 22;34(4):514-26. doi: 10.1016/j.immuni.2011.03.019. Epub 2011 Apr 14.

37.

Limited polymorphism of the Plasmodium vivax merozoite surface protein 1 gene in isolates from Turkey.

Zeyrek FY, Tachibana S, Yuksel F, Doni N, Palacpac N, Arisue N, Horii T, Coban C, Tanabe K.

Am J Trop Med Hyg. 2010 Dec;83(6):1230-7. doi: 10.4269/ajtmh.2010.10-0353.

38.

TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine.

Coban C, Horii T, Akira S, Ishii KJ.

Expert Rev Vaccines. 2010 Jul;9(7):775-84. doi: 10.1586/erv.10.60. Review.

PMID:
20624050
39.

The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells.

Shokouhi B, Coban C, Hasirci V, Aydin E, Dhanasingh A, Shi N, Koyama S, Akira S, Zenke M, Sechi AS.

Biomaterials. 2010 Aug;31(22):5759-71. doi: 10.1016/j.biomaterials.2010.04.015. Epub 2010 May 8.

PMID:
20452017
40.

Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes.

Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, Sakurai K, Coban C, Horii T, Akira S, Ishii KJ.

Sci Transl Med. 2010 Mar 31;2(25):25ra24. doi: 10.1126/scitranslmed.3000759.

41.

The malarial metabolite hemozoin and its potential use as a vaccine adjuvant.

Coban C, Yagi M, Ohata K, Igari Y, Tsukui T, Horii T, Ishii KJ, Akira S.

Allergol Int. 2010 Jun;59(2):115-24. doi: 10.2332/allergolint.10-RAI-0194. Epub 2010 Apr 24. Review.

42.

Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.

Coban C, Igari Y, Yagi M, Reimer T, Koyama S, Aoshi T, Ohata K, Tsukui T, Takeshita F, Sakurai K, Ikegami T, Nakagawa A, Horii T, Nuñez G, Ishii KJ, Akira S.

Cell Host Microbe. 2010 Jan 21;7(1):50-61. doi: 10.1016/j.chom.2009.12.003.

43.

Immune interventions of human diseases through toll-like receptors.

Coban C, Ishii KJ, Akira S.

Adv Exp Med Biol. 2009;655:63-80. doi: 10.1007/978-1-4419-1132-2_7. Review.

PMID:
20047036
44.

Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome.

Reimer T, Shaw MH, Franchi L, Coban C, Ishii KJ, Akira S, Horii T, Rodriguez A, Núñez G.

Eur J Immunol. 2010 Mar;40(3):764-9. doi: 10.1002/eji.200939996.

45.

Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa.

Culleton R, Ndounga M, Zeyrek FY, Coban C, Casimiro PN, Takeo S, Tsuboi T, Yadava A, Carter R, Tanabe K.

J Infect Dis. 2009 Nov 1;200(9):1465-9. doi: 10.1086/644510.

PMID:
19803728
46.

Innate immune control of nucleic acid-based vaccine immunogenicity.

Koyama S, Coban C, Aoshi T, Horii T, Akira S, Ishii KJ.

Expert Rev Vaccines. 2009 Aug;8(8):1099-107. doi: 10.1586/erv.09.57. Review.

PMID:
19627190
47.

Innate immune response to viral infection.

Koyama S, Ishii KJ, Coban C, Akira S.

Cytokine. 2008 Sep;43(3):336-41. doi: 10.1016/j.cyto.2008.07.009. Epub 2008 Aug 9. Review.

PMID:
18694646
48.

Host innate immune receptors and beyond: making sense of microbial infections.

Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S.

Cell Host Microbe. 2008 Jun 12;3(6):352-63. doi: 10.1016/j.chom.2008.05.003. Review.

49.

Molecular and cellular mechanisms of DNA vaccines.

Coban C, Koyama S, Takeshita F, Akira S, Ishii KJ.

Hum Vaccin. 2008 Nov-Dec;4(6):453-6. Epub 2008 Nov 28. Review.

PMID:
18535407
50.

Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey.

Zeyrek FY, Babaoglu A, Demirel S, Erdogan DD, Ak M, Korkmaz M, Coban C.

Am J Trop Med Hyg. 2008 May;78(5):729-32.

PMID:
18458304

Supplemental Content

Support Center